Health

Healthy Lifestyle’s Benefits Go beyond Weight Loss

A pooled analysis of lifestyle intervention trials suggested that adopting a healthy lifestyle can confer metabolic benefits beyond weight loss (WL) alone. The study investigated how individual responses to long-term lifestyle interventions for WL affect cardiometabolic risk by pooling data from three long-term lifestyle WL-intervention trials with adherence rates of 87%, 86%, and 89%, respectively. Among 761 trial completers (mean age 50.4 years; 89% men; baseline BMI 30.1 kg/m²), the mean WL was −3.3 kg (−3.5%). Participants were categorized as Successful-WL (36%, >5% WL), Moderate-WL (36%, 0–5% WL), or WL-Resistant (28%, no WL or weight gain). Successful-WL participants showed the most pronounced improvements in multiple health indicators, but even the WL-Resistant group exhibited significant benefits, including increased HDL-cholesterol and reductions in leptin and visceral fat. Each sustained 1 kg of WL was linked to improvements in lipid profiles and insulin resistance, reductions in intrahepatic fat, and modest decreases in blood pressure. Furthermore, there were 12 DNA methylation sites significantly associated with Successful-WL. Despite only about one-third of participants achieving long-term WL, both Moderate-WL and WL-Resistant individuals experienced improvements in visceral adiposity and cardiometabolic health.  Lifestyle interventions are the backbone of cardiovascular prevention. The findings underscore the critical value of adopting a healthy lifestyle and the measurable benefits it can yield. Source: https://academic.oup.com/eurjpc/

hyangiu

Recent Posts

Lifestyle Intervention May Slow Early Cerebral Small-Vessel Injury

A secondary MRI analysis of the US POINTER randomized clinical trial found that a structured…

10 hours ago

Shared and Region-Specific Dementia Risk Factors

Dementia risk factors vary substantially across countries, but they frequently cluster together in similar patterns…

16 hours ago

Comparative Benefits and Risks of Anti-Obesity Drugs

A systematic review and network meta-analysis of 262 randomized trials involving 99,791 participants found that…

4 days ago

Early Mild Hypertrophic Cardiomyopathy May Still Carry Significant Cardiovascular Risk

Approximately 21% of patients with phenotypically mild hypertrophic cardiomyopathy (HCM) experienced major adverse cardiovascular events…

5 days ago

High-Intensity Interval Exercise Reduces Energy Intake in Adults With Overweight or Obesity

A Danish randomized crossover trial found that a single session of high-intensity interval exercise (HIIE)…

6 days ago

Proton Pump Inhibitor and Antibiotic Use May Reduce the Benefit of Immunotherapy in NSCLC

Baseline use of proton pump inhibitors (PPIs) and, to a lesser extent, antibiotics was associated…

1 week ago

This website uses cookies.